王帝之, 李省天, 李鑫铭, 马新东. 2023: 健康中国战略下运动处方的临床实践. 体育科学, 43(11): 89-97. DOI: 10.16469/j.css.202311010
    引用本文: 王帝之, 李省天, 李鑫铭, 马新东. 2023: 健康中国战略下运动处方的临床实践. 体育科学, 43(11): 89-97. DOI: 10.16469/j.css.202311010
    WANG Di-zhi, LI Sheng-tian, LI Xin-ming, MA Xin-dong. 2023: Clinical Practice of Exercise Prescription Under the Healthy China Strategy. China Sport Science, 43(11): 89-97. DOI: 10.16469/j.css.202311010
    Citation: WANG Di-zhi, LI Sheng-tian, LI Xin-ming, MA Xin-dong. 2023: Clinical Practice of Exercise Prescription Under the Healthy China Strategy. China Sport Science, 43(11): 89-97. DOI: 10.16469/j.css.202311010

    健康中国战略下运动处方的临床实践

    Clinical Practice of Exercise Prescription Under the Healthy China Strategy

    • 摘要: 运动处方是实施体医融合模式的关键一环。目前,运动处方制定的理论框架日臻完善,但应用性、安全性和有效性一直都是限制其在临床实践中大范围推广的瓶颈。研究认为,可以通过以下策略打破运动处方的现实困境:1)完善运动前健康评价体系,扩大运动处方的临床应用;2)丰富临床运动测试,确保运动处方的安全性;3)制定周期性循证运动处方,优化运动处方的有效性。

       

      Abstract: Exercise prescription is the key part in the implementation of the physical-medical integration model. Currently, the theoretical framework of exercise prescription formulation has improved; however, the applicability, safety and effectiveness are core factors that limit the widespread application of exercise prescription in clinical practice. To address these issues, the study proposes several strategies: 1) Improve the pre-exercise health evaluation system so as to expand the clinical application of exercise prescriptions; 2) clinical exercise tests should be used to ensure the safety of exercise prescription; 3) optimize the effectiveness of exercise prescription by formulating periodic evidence-informed exercise prescription.

       

    /

    返回文章
    返回